Enovix (NASDAQ:ENVX – Get Free Report) posted its earnings results on Wednesday. The company reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.16) by $0.02, FiscalAI reports. The firm had revenue of $7.99 million for the quarter, compared to analyst estimates of $7.94 million. Enovix had a negative return on equity of 66.18% and a negative net margin of 525.93%.Enovix’s revenue was up 86.0% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.17) EPS. Enovix updated its Q4 2025 guidance to -0.200–0.160 EPS.
Enovix Stock Performance
Shares of NASDAQ ENVX traded down $0.01 during midday trading on Friday, hitting $9.02. The company’s stock had a trading volume of 2,477,361 shares, compared to its average volume of 6,913,169. The company has a debt-to-equity ratio of 0.82, a quick ratio of 4.11 and a current ratio of 4.37. The firm’s fifty day moving average price is $10.80 and its 200-day moving average price is $10.17. Enovix has a 1-year low of $5.27 and a 1-year high of $16.49. The firm has a market cap of $1.77 billion, a P/E ratio of -11.04 and a beta of 2.09.
Insider Activity
In related news, COO Ajay Marathe sold 18,614 shares of the company’s stock in a transaction on Wednesday, October 8th. The stock was sold at an average price of $13.00, for a total transaction of $241,982.00. Following the completion of the transaction, the chief operating officer directly owned 1,002,684 shares in the company, valued at $13,034,892. This represents a 1.82% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 14.10% of the company’s stock.
Institutional Trading of Enovix
Wall Street Analysts Forecast Growth
A number of research analysts recently weighed in on ENVX shares. JPMorgan Chase & Co. restated a “neutral” rating and issued a $12.00 price objective (up previously from $9.00) on shares of Enovix in a report on Thursday, July 24th. Wall Street Zen lowered Enovix from a “hold” rating to a “sell” rating in a report on Saturday, September 6th. B. Riley reaffirmed a “buy” rating and set a $17.00 price objective (up from $12.00) on shares of Enovix in a research report on Thursday, July 10th. Canaccord Genuity Group reduced their target price on shares of Enovix from $22.00 to $21.00 and set a “buy” rating for the company in a report on Thursday. Finally, Cantor Fitzgerald lowered their target price on Enovix from $30.00 to $25.00 and set an “overweight” rating on the stock in a research note on Thursday. Five investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $17.89.
Check Out Our Latest Analysis on Enovix
About Enovix
Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Featured Stories
- Five stocks we like better than Enovix
- How to Use the MarketBeat Dividend Calculator
- Netflix Stock Split Explained: What It Means for Investors
- The Most Important Warren Buffett Stock for Investors: His Own
- SoundHound Beat Earnings & Dropped—Here’s What Wall Street Missed
- Stock Analyst Ratings and Canadian Analyst Ratings
- AI Trade Over? Datadog Results Say It’s Gaining Momentum
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.
